Metabolic fatty liver disease affects almost 30% of the population, and 80% of those who are obese. The disease has no cure, but its progression can1
The study was led by Jordi Gracia Sancho, the head of the IDIBAPS group Liver vascular biology and a researcher at CIBEREHD. The first authors are Da1
The Hospital Clínic Barcelona recently exceeded 2,500 liver transplants, thus becoming the Catalan hospital most active in this type of procedure. Th1
Researchers at the Hospital Clínic-IDIBAPS led an international study, published in the journal The Lancet, in which they designed an index to determ1
Dr. Antonio Alcaraz performed kidney surgery using this system, which will allow more patients to be operated on at a lower cost
Interview with Dr Maria Reig, head of the Hepatic Oncology Unit
IDIBAPS researchers have published in Nature Protocols the process for the directed differentiation of human induced pluripotent stem cells (iPSCs) i1
A study published in GUT, jointly led by Ki Up Lee of the University of Ulsan, South Korea, and José C. Fernández-Checa, leader of the IDIBAPS-IIBB-C1
A study published in the journal Nature Medicine proposes a paradigm shift in the approach to steatohepatitis, the most advanced degree of non-alcoho1
IDIBAPS researchers have published a series of three studies in which describe the impact of aging on the liver biology and function, both in healthy1
